New drug trial offers hope for dialysis patients battling anemia
NCT ID NCT03402386
Summary
This study tested a drug called MT-6548 to see if it could safely and effectively treat anemia (low red blood cells) in people with chronic kidney disease who use peritoneal dialysis. It involved 42 participants in Japan who were either starting anemia treatment or switching from their current medication. The main goal was to see if the drug could raise and maintain healthy hemoglobin levels over 24 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA; PERITONEAL DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research site
Aichi, Japan
-
Research site
Chiba, Japan
-
Research site
Fukuoka, Japan
-
Research site
Fukushima, Japan
-
Research site
Gunma, Japan
-
Research site
Hokkaido, Japan
-
Research site
Hyōgo, Japan
-
Research site
Ibaraki, Japan
-
Research site
Kagoshima, Japan
-
Research site
Kanagawa, Japan
-
Research site
Kyoto, Japan
-
Research site
Nagano, Japan
-
Research site
Nara, Japan
-
Research site
Okayama, Japan
-
Research site
Okinawa, Japan
-
Research site
Shiga, Japan
-
Research site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.